Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: Am J Cardiol. 2008 May 2;102(1):64–69. doi: 10.1016/j.amjcard.2008.02.097

Figure 1.

Figure 1

Comparison of treatment-associated changes (post minus baseline) in body weight and SSPG concentrations among the fenofibrate (FEN), rosiglitazone (RSG), and calorie-restricted diet (CRD) groups.

p value indicates significance of difference among the 3 groups by one-way ANOVA. *Tukey’s pairwise comparisons: A) CRD vs. RSG (p<0.001) and CRD vs. FEN (p<0.001); and B) RSG vs. FEN (p=0.004) and RSG vs. CRD (p=0.02).